Role of immunology in UTI becoming increasingly clear
April 15th 2004It is becoming increasingly clear that immunology plays a large role in urinary tract infections and potentially in their cure. One new theory is that bacteria can influence the host's immune response by down-regulating it, suppressing the immune system and preventing the host from responding in a normal way.
DNA integrity studies yield key findings on infertility
April 15th 2004Most practicing urologists have little time to closely examine the basicscience behind advances in male infertility, but the lab work that researchersare performing in this subspecialty today is poised to dramatically affectthe way urology is practiced tomorrow.
Form of vitamin E reduces risk of bladder cancer
April 15th 2004Alpha-tocopherol, a form of vitamin E, protects against the development of bladder cancer, while a second type of vitamin E, gamma-tocopherol, appears to offer no protection, according to research by the University of Texas M.D. Anderson Cancer Center in Houston.
Enigmatic disorder begins to yield to research
April 1st 2004This issue of Urology Times includes a number of articles from one ofthe most successful meetings on interstitial cystitis ever held, the NationalInstitute of Diabetes, Digestive, and Kidney Disorders and InterstitialCystitis Association joint symposium "Research Insights into InterstitialCystitis" in Alexandria, VA, last fall.
DHEA may increase risk of BPH, study shows
March 31st 2004Dehydroepiandrosterone (DHEA), a popular supplement among athletes, does not increase testosterone levels and may, in fact, break down into hormones associated with prostate gland growth, according to results of a small study from the Keck School of Medicine at the University of Southern California, Los Angeles.
PCa prevention with 5-ARIs: What to tell patients
March 1st 2004A major breakthrough in the field of prostate cancer research was announced last summer. For the first time in a randomized clinical trial, a drug was found to reduce the risk of prostate cancer. Widely reported headlines such as "Drug might prevent prostate cancer, researchers say" (USA Today, June 25, 2003, page 1) were tempered by reports of the drug's "disturbing" side effects.
Therapeutic cloning is used to generate renal cells
March 1st 2004Chicago--Therapeutic cloning can be used to generate immune-compatible renal cells, according to the results of a collaborative study from the Laboratory for Tissue Engineering, Children's Hospital, Harvard Medical School, Boston, and Advanced Cell Technology, Worcester, MA. The technique may be used to engineer renal tissue for autologous applications, researchers suggest.